Genetic Technologies
GENE
#10486
Rank
โ‚น0.33 B
Marketcap
โ‚น68.77
Share price
0.00%
Change (1 day)
-66.72%
Change (1 year)

Genetic Technologies (GENE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น0.26 Billion

According to Genetic Technologies's latest financial reports the company's total liabilities are โ‚น0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Genetic Technologies - Total liabilities on balance sheet (from 2004 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-06-30โ‚น0.24 B21.14%
2023-06-30โ‚น0.20 B-15.5%
2022-06-30โ‚น0.23 B195.38%
2021-06-30โ‚น80.39 M-5.85%
2020-06-30โ‚น85.38 M18.08%
2019-06-30โ‚น72.31 M-1.85%
2018-06-30โ‚น73.67 M-2.98%
2017-06-30โ‚น75.94 M7.09%
2016-06-30โ‚น70.91 M-17.44%
2015-06-30โ‚น85.89 M-68.97%
2014-06-30โ‚น0.27 B98.65%
2013-06-30โ‚น0.13 B20.19%
2012-06-30โ‚น0.11 B15.32%
2011-06-30โ‚น0.10 B0.5%
2010-06-30โ‚น0.10 B-32.92%
2009-06-30โ‚น0.14 B9.59%
2008-06-30โ‚น0.13 B18.52%
2007-06-30โ‚น0.11 B-20.12%
2006-06-30โ‚น0.14 B-33.48%
2005-06-30โ‚น0.21 B28.43%
2004-06-30โ‚น0.16 B101.33%
2003-06-30โ‚น83.56 M46.46%
2002-06-30โ‚น57.05 M57.41%
2001-06-30โ‚น36.24 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.23 B-10.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚น31.94 B 12,086.42%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น858.38 B 327,407.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น792.97 B 302,451.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น4.85 B 1,752.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚น2.590 T 988,293.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.662 T 1,778,850.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น113.22 B 43,099.89%๐Ÿ‡บ๐Ÿ‡ธ USA